These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21670179)

  • 1. Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins.
    Yamaki J; Synold T; Wong-Beringer A
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4432-5. PubMed ID: 21670179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus.
    Hodille E; Beraud L; Périan S; Berti V; Bes M; Tristan A; Blond E; Lina G; Dumitrescu O
    Microbiol Spectr; 2022 Feb; 10(1):e0080821. PubMed ID: 35044221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline induction of phenol-soluble modulins by invasive methicillin-resistant Staphylococcus aureus strains.
    Yamaki J; Synold T; Wong-Beringer A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4562-5. PubMed ID: 23817369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
    Katahira EJ; Davidson SM; Stevens DL; Bolz DD
    J Med Microbiol; 2019 Feb; 68(2):255-262. PubMed ID: 30556803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
    Dumitrescu O; Badiou C; Bes M; Reverdy ME; Vandenesch F; Etienne J; Lina G
    Clin Microbiol Infect; 2008 Apr; 14(4):384-8. PubMed ID: 18261123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
    Louie A; Liu W; Kulawy R; Drusano GL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3453-60. PubMed ID: 21502615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Costello AJ; Kroeger JS; Biek D; Critchley IA; Diekema DJ; Doern GV
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4154-60. PubMed ID: 21709080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
    Prokocimer P; Bien P; Deanda C; Pillar CM; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
    J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.
    LaPlante KL; Leonard SN; Andes DR; Craig WA; Rybak MJ
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2156-62. PubMed ID: 18411321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymol Reduces
    Lade H; Chung SH; Lee Y; Kumbhar BV; Joo HS; Kim YG; Yang YH; Kim JS
    Biomed Res Int; 2022; 2022():8221622. PubMed ID: 35586806
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased in vitro phenol-soluble modulin production is associated with soft tissue infection source in clinical isolates of methicillin-susceptible Staphylococcus aureus.
    Qi R; Joo HS; Sharma-Kuinkel B; Berlon NR; Park L; Fu CL; Messina JA; Thaden JT; Yan Q; Ruffin F; Maskarinec S; Warren B; Chu VH; Fortes CQ; Giannitsioti E; Durante-Mangoni E; Kanafani ZA; Otto M; Fowler VG
    J Infect; 2016 Mar; 72(3):302-8. PubMed ID: 26778460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenol-soluble modulins α are major virulence factors of
    Damour A; Robin B; Deroche L; Broutin L; Bellin N; Verdon J; Lina G; Leclère FM; Garcia M; Cremniter J; Lévêque N; Bodet C
    Virulence; 2021 Dec; 12(1):2474-2492. PubMed ID: 34516337
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of tedizolid and other comparator drugs in methicillin-resistant Staphylococcus aureus isolates in skin and soft tissue infections in seven Colombian hospitals.
    Leal AL; Ovalle MV; Cortés JA; Montañes AM; De la Rosa ZR; Rodríguez JY; Gualtero S; Ariza B; Sussman O; Torres MDP
    Biomedica; 2018 Dec; 38(4):507-513. PubMed ID: 30653864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Staphylococcus aureus biofilm-forming functional amyloid by molecular tweezers.
    Malishev R; Salinas N; Gibson J; Eden AB; Mieres-Perez J; Ruiz-Blanco YB; Malka O; Kolusheva S; Klärner FG; Schrader T; Sanchez-Garcia E; Wang C; Landau M; Bitan G; Jelinek R
    Cell Chem Biol; 2021 Sep; 28(9):1310-1320.e5. PubMed ID: 33852903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
    Joo HS; Chan JL; Cheung GY; Otto M
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4942-4. PubMed ID: 20713669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
    Werth BJ
    J Antimicrob Chemother; 2017 May; 72(5):1410-1414. PubMed ID: 28158617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
    Anderegg TR; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2662-4. PubMed ID: 12121951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.